GenusPlus Group Limited Logo

GenusPlus Group Limited

GNP.AX

(2.5)
Stock Price

2,61 AUD

11.62% ROA

28.31% ROE

15.45x PER

Market Cap.

476.303.000,00 AUD

12.05% DER

0.93% Yield

3.44% NPM

GenusPlus Group Limited Stock Analysis

GenusPlus Group Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

GenusPlus Group Limited Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (17.94%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 DER

The stock has a minimal amount of debt (29%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 ROA

The stock's ROA (6.85%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

4 PBV

The stock's PBV ratio (1.91x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

5 Revenue Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

6 Net Profit Growth

This company's net profit has consistently grown over the past three years, showcasing a positive financial trend and making it an appealing investment opportunity.

7 Assets Growth

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

8 Buffet Intrinsic Value

The company's stock seems undervalued (36) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

9 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

10 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

11 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

GenusPlus Group Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

GenusPlus Group Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

GenusPlus Group Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

GenusPlus Group Limited Revenue
Year Revenue Growth
2018 11.854.204
2019 99.166.632 88.05%
2020 169.955.735 41.65%
2021 318.207.504 46.59%
2022 451.148.411 29.47%
2023 444.178.894 -1.57%
2024 1.204.932.616 63.14%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

GenusPlus Group Limited Research and Development Expenses
Year Research and Development Expenses Growth
2018 0
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

GenusPlus Group Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2018 1.688.919
2019 4.782.049 64.68%
2020 0 0%
2021 87.150.489 100%
2022 138.077.102 36.88%
2023 141.904.405 2.7%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

GenusPlus Group Limited EBITDA
Year EBITDA Growth
2018 984.830
2019 11.666.840 91.56%
2020 15.010.500 22.28%
2021 26.655.136 43.69%
2022 32.020.879 16.76%
2023 33.737.000 5.09%
2024 85.099.320 60.36%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

GenusPlus Group Limited Gross Profit
Year Gross Profit Growth
2018 3.213.423
2019 18.539.482 82.67%
2020 21.018.408 11.79%
2021 221.546.885 90.51%
2022 311.849.519 28.96%
2023 43.544.096 -616.17%
2024 120.673.796 63.92%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

GenusPlus Group Limited Net Profit
Year Net Profit Growth
2018 490.754
2019 6.012.740 91.84%
2020 10.689.642 43.75%
2021 13.348.769 19.92%
2022 13.556.475 1.53%
2023 13.405.524 -1.13%
2024 40.850.288 67.18%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

GenusPlus Group Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2018 0
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

GenusPlus Group Limited Free Cashflow
Year Free Cashflow Growth
2018 1.622.283
2019 816.206 -98.76%
2020 29.948.332 97.27%
2021 -4.303.347 795.93%
2022 6.602.817 165.17%
2023 32.093.628 79.43%
2024 52.924.211 39.36%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

GenusPlus Group Limited Operating Cashflow
Year Operating Cashflow Growth
2018 1.622.283
2019 4.360.653 62.8%
2020 37.420.490 88.35%
2021 6.991.137 -435.26%
2022 11.473.283 39.07%
2023 37.790.820 69.64%
2024 62.910.781 39.93%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

GenusPlus Group Limited Capital Expenditure
Year Capital Expenditure Growth
2018 0
2019 3.544.447 100%
2020 7.472.158 52.56%
2021 11.294.484 33.84%
2022 4.870.466 -131.9%
2023 5.697.192 14.51%
2024 9.986.570 42.95%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

GenusPlus Group Limited Equity
Year Equity Growth
2018 18.779.615
2019 24.792.355 24.25%
2020 46.179.000 46.31%
2021 57.710.210 19.98%
2022 93.423.073 38.23%
2023 104.976.133 11.01%
2024 121.166.442 13.36%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

GenusPlus Group Limited Assets
Year Assets Growth
2018 44.029.391
2019 49.421.471 10.91%
2020 122.156.000 59.54%
2021 155.555.750 21.47%
2022 231.983.896 32.95%
2023 227.418.572 -2.01%
2024 288.150.398 21.08%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

GenusPlus Group Limited Liabilities
Year Liabilities Growth
2018 25.249.776
2019 24.629.116 -2.52%
2020 75.977.000 67.58%
2021 97.845.540 22.35%
2022 138.560.823 29.38%
2023 122.442.439 -13.16%
2024 166.983.956 26.67%

GenusPlus Group Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
5.04
Net Income per Share
0.17
Price to Earning Ratio
15.45x
Price To Sales Ratio
0.53x
POCF Ratio
4.12
PFCF Ratio
4.99
Price to Book Ratio
3.93
EV to Sales
0.45
EV Over EBITDA
6.03
EV to Operating CashFlow
3.5
EV to FreeCashFlow
4.24
Earnings Yield
0.06
FreeCashFlow Yield
0.2
Market Cap
0,48 Bil.
Enterprise Value
0,40 Bil.
Graham Number
1.63
Graham NetNet
0.02

Income Statement Metrics

Net Income per Share
0.17
Income Quality
3.75
ROE
0.28
Return On Assets
0.11
Return On Capital Employed
0.28
Net Income per EBT
0.69
EBT Per Ebit
1.06
Ebit per Revenue
0.05
Effective Tax Rate
0.3

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.19
Operating Profit Margin
0.05
Pretax Profit Margin
0.05
Net Profit Margin
0.03

Dividends

Dividend Yield
0.01
Dividend Yield %
0.93
Payout Ratio
0.17
Dividend Per Share
0.03

Operating Metrics

Operating Cashflow per Share
0.65
Free CashFlow per Share
0.54
Capex to Operating CashFlow
0.17
Capex to Revenue
0.02
Capex to Depreciation
0.76
Return on Invested Capital
0.22
Return on Tangible Assets
0.12
Days Sales Outstanding
37.41
Days Payables Outstanding
37.67
Days of Inventory on Hand
1.42
Receivables Turnover
9.76
Payables Turnover
9.69
Inventory Turnover
256.18
Capex per Share
0.11

Balance Sheet

Cash per Share
0,57
Book Value per Share
0,68
Tangible Book Value per Share
0.55
Shareholders Equity per Share
0.68
Interest Debt per Share
0.1
Debt to Equity
0.12
Debt to Assets
0.05
Net Debt to EBITDA
-1.07
Current Ratio
1.46
Tangible Asset Value
0,10 Bil.
Net Current Asset Value
0,04 Bil.
Invested Capital
140529491
Working Capital
0,06 Bil.
Intangibles to Total Assets
0.08
Average Receivables
0,09 Bil.
Average Payables
0,07 Bil.
Average Inventory
3025584
Debt to Market Cap
0.03

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

GenusPlus Group Limited Dividends
Year Dividends Growth
2021 0
2022 0 0%
2023 0 0%
2024 0 0%

GenusPlus Group Limited Profile

About GenusPlus Group Limited

GenusPlus Group Limited engages in the installation, construction, and maintenance of power and communication systems in Australia. The company operates through three segments: Power Services, Telecommunications, and Industrial Services. It offers various services, including planning, designing, constructing, operating, testing, maintaining, managing, and decommissioning power network assets for electricity utilities, infrastructure developers, telecommunications networks, and mining companies. The company also provides electrical and instrumentation, and mechanical services to mining, oil and gas, infrastructure, and power generation sectors; and turnkey communications solutions, such as feasibility, engineering design, site acquisition, logistics, procurement, construction, and integration. GenusPlus Group Limited was incorporated in 2017 and is headquartered in Belmont, Australia.

CEO
Mr. David William Riches
Employee
0
Address
63 – 69 Abernethy Road
Belmont, 6104

GenusPlus Group Limited Executives & BODs

GenusPlus Group Limited Executives & BODs
# Name Age
1 Mr. Damian R. Wright A.C.I.S., ACIS, B.Com., B.Comm, C.P.A., CPA, GradD
Chief Financial Officer & Joint Company Secretary
70
2 George Lloyd
EGM of National Business Development
70
3 Mr. Efstratios Vassilios Gregoriadis B.A., L.L.B., M.B.A.
General Counsel & Joint Company Secretary
70
4 Michael Green
EGM of Corporate Services
70
5 Mr. David William Riches
Founder, Chief Executive Officer, MD & Director
70
6 Hasan Murad
EGM of Commercial
70

GenusPlus Group Limited Competitors

Cogstate Limited Logo
Cogstate Limited

CGS.AX

(1.8)
PWR Holdings Limited Logo
PWR Holdings Limited

PWH.AX

(3.5)
LiveChat Software S.A. Logo
LiveChat Software S.A.

LVC.WA

(2.8)
MedPeer,Inc. Logo
MedPeer,Inc.

6095.T

(2.5)
Redbubble Limited Logo
Redbubble Limited

RBL.AX

(1.0)